Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
98.46 USD | +0.26% | +4.54% | +6.04% |
Strengths
- Analysts covering this company mostly recommend stock overweighting or purchase.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- The company benefits from high valuations in earnings multiples.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+6.04% | 1.59B | C | ||
-3.03% | 3.01B | B- | ||
0.00% | 1.97B | - | ||
+54.71% | 643M | D+ | ||
-4.83% | 511M | - | ||
-33.81% | 368M | - | ||
-26.04% | 147M | - | ||
-11.94% | 142M | - | ||
+1.92% | 67.85M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ADUS Stock
- Ratings Addus HomeCare Corporation